I027Osteosarcopenia in a clinical setting: how is it diagnosed, and what are the clinical consequences?OSTEOPOROSIS diagnosisOSTEOPOROSISDISEASE complicationsSARCOPENIADIAGNOSISdoi:10.1093/rheumatology/kez109.026Celia GregsonRheumatology
Relationship between Adherence Level to Statins, Clinical Issues and Health-Care Costs in Real-Life Clinical Setting ObjectiveStatins have been shown to reduce the risk of major cardiovascular disease. We recognize that there is a major gap between the use of statins in a......
On the surface, an anxiety hierarchy usually isn’t difficult to develop. It can simply be a list of ways you could be exposed to your fear and how intense the distress is for each situation. Inclinical settings, anxiety hierarchies are often discussed in clinical terms. They can be used ...
theory these behaviours arepresented as in-group pain management social norms; part of the culture of'how pain management is done around here'.These pain management in-group behaviours are presented as the criticalfactors influencing nurses' pain management decision-making in a clinicalsetting. They...
47 The final guidance is still pending. Through these initiatives, regulators are hoping to standardize preclinical and clinical cardiovascular testing of all drugs, an important endeavor in enhancing efforts at risk management of QT-prolonging medications. Equally important, however, is the clear ...
(2014) What is the risk of clinical anastomotic leak in the diverted colorectal anastomosis? J Gastrointest Surg 18: 1812-1816.Leahy J, Schoetz D, Marcello P et al (2014) What is the risk of clinical anastomotic leak in the diverted colorectal anastomosis? J Gastrointest Surg 18(10):1812...
Does Obesity Put Me at Risk for Other Conditions? Obesity rarely occurs in a bubble. While some people may be obese and have no serious co-existing medical conditions, they are the exception. As the second leading cause of preventable death in the U.S. (behind smoking),obesity is a serio...
Antimicrobial resistance (AMR) causes high levels of global mortality. There is a global need to develop new antimicrobials to replace those whose efficacy is being eroded, but limited incentive for companies to engage in R&D, and a limited pipeline
I said to Andrew, everything has to be validated, of course, that the benefit greatly outweighs any risk. But it is really a remarkable time for the future of health care, it's so damn exciting. 我想以最近与我的同事的对话收尾。医学仍然...
investors. For instance, if a company is researching the efficacy of a new drug or vaccine, it must complete clinical trials with suitable results before it can be sold and used. Companies that receive approvals can see major upsides in their stocks while those that are rejected may ...